Börsinformation

Issuer Abliva AB

Holder

Maas Biolab, LLC

Instrument
Instrument	Common
Before the transaction
Shares	4,233,736
Voting rights	4,233,736
Transaction
Reason for major shareholding notification	Corporate action
Date	13/03/2014
Limit for number of shares	20 %
Limit for number of votes	20 %
After the transaction
Quantity
Shares	4,233,736
Directly held voting rights	4,233,736
Indirectly held voting rights	0
Percentage
Directly held shares	15.2 %
Directly held voting rights	15.2 %
Indirectly held voting rights	0 %

Resulting distribution of total holdings
		Percentage of voting rights:	Number of underlying shares:
Shares
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
-	Physically settled
-	Cash settled
Total

Group total holdings
Voting rights	4,233,736
Percentage of voting rights	15.2

Notes (other relevant informations according to law)

Beräknat på totalt 27 788 093 utstående aktier

Published

21/03/2014 15:09

Contact
Name	Marcus Keep
Phone*	***	Email*	***

*)	Note that neither phone nor email is published on fi.se
	The legal basis for FI to compile and publish these so-called major shareholding notification announcements is that this document is necessary for FI to carry out a task in the public interest (Article 6(1)(e) of the General Data Protection Regulation). Chapter 4 of Act (1991:980) sets forth that major shareholders are obligated under certain conditions to notify FI when buying or selling shares and that FI must disclose this information. Chapter 12, sections 10–11 of FFFS 2007:17 specifies the required content of the major shareholding notification. Read more about FI’s processing of personal data here www.fi.se/sv/om-fi/dataskydd-och-behandling-av-personuppgifter-pa-fi/

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25